Whole-owned intellectual property rights

The CAR-T platform of EXCYTE will explore the CAR-T platform with independent intellectual property, including the co-stimulatory molecules such as CD28 and 4-1BB.

<m met-id=86 met-table=news met-field=keywords></m>

The CAR-T platform of EXCYTE will explore the CAR-T platform with independent intellectual property, including the co-stimulatory molecules such as CD28 and 4-1BB.